<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2080">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05134090</url>
  </required_header>
  <id_info>
    <org_study_id>1514/21</org_study_id>
    <nct_id>NCT05134090</nct_id>
  </id_info>
  <brief_title>Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation.</brief_title>
  <official_title>Percutaneous Laparoscopy for Ovarian Tissue Cryopreservation: a Single-center Experience.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regina Elena Cancer Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regina Elena Cancer Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare surgical outcomes of oncologic patients that underwent conventional laparoscopy&#xD;
      and percutaneous laparoscopy for cryopreservation of ovarian tissue.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a retrospective analysis to evaluate the efficacy and safety of percutaneous&#xD;
      laparoscopy for the ovarian tissue explant in oncologic women. Surgical outcomes of patients&#xD;
      that underwent percutaneous laparoscopy were compared with those of women that underwent&#xD;
      conventional laparoscopy. Data from 2017 to 2021 were collected in a single Oncologic Center&#xD;
      in Italy. The principal outcomes considered are post-operative pain, recovery time and&#xD;
      aesthetic outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 10, 2021</start_date>
  <completion_date type="Actual">August 1, 2021</completion_date>
  <primary_completion_date type="Actual">July 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative pain</measure>
    <time_frame>0-1 and 2 days after surgery</time_frame>
    <description>Post-operative pain is evaluated with VAS score ranging from 1 to 10 (higher score, maximum pain)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Aesthetic outcomes</measure>
    <time_frame>minimum 3 months after surgery</time_frame>
    <description>General satisfaction regarding aesthetic outcomes is collected with a satisfaction survey. The score ranged from 1 to 5, with 1 indicating &quot;very dissatisfied&quot; and 5 &quot;very satisfied&quot;.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Recovery time</measure>
    <time_frame>Days</time_frame>
    <description>Time from surgical intervention to discharge in days</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>1 day</time_frame>
    <description>Time of operation in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood loss</measure>
    <time_frame>1 day</time_frame>
    <description>Entity of blood loss during surgery in ml</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgical complications</measure>
    <time_frame>30 days</time_frame>
    <description>The presence of absence of intra and post-operative complications (yes or not and type)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">59</enrollment>
  <condition>Oncology</condition>
  <condition>Fertility Issues</condition>
  <condition>Surgery</condition>
  <arm_group>
    <arm_group_label>Percutaneous laparoscopy</arm_group_label>
    <description>Laparoscopy with percutaneous grasp (2.9 mm).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional laparoscopy</arm_group_label>
    <description>Conventional laparoscopy with conventional laparoscopic trocars (10 or 5 mm).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ovaian tissue explant</intervention_name>
    <description>Ovarian tissue explant for cryopreservation of ovarian tissue</description>
    <arm_group_label>Conventional laparoscopy</arm_group_label>
    <arm_group_label>Percutaneous laparoscopy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Women with histological diagnosis of malignancy during reproductive age undergoing ovarian&#xD;
        tissue explant for ovarian tissue cryopreservation, from Aug 2017 to Jun 2021.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Oncologic women with desire to preserve fertility&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ovarian explant with different techniques than laparoscopy&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Benito Chiofalo</last_name>
    <role>Principal Investigator</role>
    <affiliation>IRCCS &quot;Regina Elena&quot; National Cancer Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IRCCS &quot;Regina Elena&quot; National Cancer Institute</name>
      <address>
        <city>Rome</city>
        <state>Lazio</state>
        <zip>00144</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>August 11, 2021</study_first_submitted>
  <study_first_submitted_qc>November 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 24, 2021</study_first_posted>
  <last_update_submitted>November 15, 2021</last_update_submitted>
  <last_update_submitted_qc>November 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Regina Elena Cancer Institute</investigator_affiliation>
    <investigator_full_name>Benito Chiofalo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Percuvataneous laparoscopy</keyword>
  <keyword>Ovarian Tissue Cryopreservation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

